Abstract:Brain edema is one of the fatal pathologies after subarachnoid hemorrhage (SAH). Previous research suggested that increased microvascular permeability might be a primary contributor to brain edema. Normally, the vascular endothelial barrier is maintained by 2 key junctions between endothelial cells, tight junctions (TJs), and adherens junctions (AJs). In the past 2 decades, much attention has been paid to the involvement of TJs in the increased vascular permeability after SAH. However, the integrity of AJs is also critical in maintaining microvascular permeability, and disruption of AJs can lead to interstitial edema. AJs comprise transmembrane protein vascular endothelial (VE)-cadherin and α-, β-, γ-, and δ-catenins in the cytoplasm. Inhibition of VE-cadherin by homophilic binding resulted in increased microvascular permeability. Protease-activated receptor-1, -3, and -4 (PAR-1, 3, and 4, but not PAR-2) are thrombin receptors, which are a subfamily of G-protein–coupled receptors. PAR-1 is a major receptor on the endothelial cells. PAR-1 activation increases the activity of downstream protein kinases, such as c-Src and p21activated kinase-1 (PAK1), which leads to phosphorylation of key target proteins. Before PAR-1 orchestrates its actions, it must be activated by thrombin, which increased in plasma after SAH. Although PAR-1 activation could lead to cerebral vasospasm, its role in increasing microvascular permeability after SAH is not clear yet. Background and Purpose—Plasma thrombin concentration is increased after subarachnoid hemorrhage (SAH). However, the role of thrombin receptor (protease-activated receptor-1 [PAR-1]) in endothelial barrier disruption has not been studied. The aims of this study were to investigate the role of PAR-1 in orchestrating vascular permeability and to assess the potential therapeutics of a PAR-1 antagonist, SCH79797, through maintaining vascular integrity. Methods—SCH79797 was injected intraperitoneally into male Sprauge-Dawley rats undergoing SAH by endovascular perforation. Assessment was conducted at 24 hours after SAH for brain water content, Evans blue content, and neurobehavioral testing. To explore the role of PAR-1 activation and the specific mechanism of SCH79797’s effect after SAH, Western blot, immunoprecipitation, and immunofluorescence of hippocampus tissue were performed. A p21activated kinase-1 (PAK1) inhibitor, IPA-3, was used to explore the underlying protective mechanism of SCH79797. Results—At 24 hours after SAH, animals treated with SCH79797 demonstrated a reduction in brain water content, Evans blue content, and neurobehavioral deficits. SCH79797 also attenuated PAR-1 expression and maintained the level of vascular endothelial-cadherin, an important component of adherens junctions. Downstream to PAR-1, c-Src–dependent activation of p21-activated kinase-1 led to an increased serine/threonine phosphorylation of vascular endothelialcadherin; immunoprecipitation results revealed an enhanced binding of phosphorylated vascular endothelial-cadherin with endocytosis orchestrator β-arrestin-2. These pathological states were suppressed after SCH79797 treatment. Conclusions—PAR-1 activation after SAH increases microvascular permeability, at least, partly through a PAR-1-c-Srcp21-activated kinase-1-vascular endothelial-cadherin phosphorylation pathway. Through suppressing PAR-1 activity, SCH79797 plays a protective role in maintaining microvascular integrity after SAH. (Stroke. 2013;44:1410-1417.)

CD47 Blockade Accelerates Blood Clearance and Alleviates Early Brain Injury After Experimental Subarachnoid Hemorrhage

CD47 blocking antibody accelerates hematoma clearance and alleviates hydrocephalus after experimental intraventricular hemorrhage

Blocking B7-1/CD28 Pathway Diminished Long-Range Brain Damage by Regulating the Immune and Inflammatory Responses in a Mouse Model of Intracerebral Hemorrhage

PARP Inhibition Attenuates Early Brain Injury Through NF-κB/MMP-9 Pathway in a Rat Model of Subarachnoid Hemorrhage.

Ly6C-high monocytes alleviate brain injury in experimental subarachnoid hemorrhage in mice

Inhibition of CCR1 attenuates neuroinflammation via the JAK2/STAT3 signaling pathway after subarachnoid hemorrhage

Minocycline Protects Against NLRP3 Inflammasome-Induced Inflammation and P53-Associated Apoptosis in Early Brain Injury after Subarachnoid Hemorrhage

Abstract T P232: Brain CD47 Expression in a Piglet Model of Intracerebral Hemorrhage

CX3CL1/CX3CR1 axis attenuates early brain injury via promoting the delivery of exosomal microRNA-124 from neuron to microglia after subarachnoid hemorrhage

Brain CD47 Expression in a Swine Model of Intracerebral Hemorrhage.

Rh-CXCL-12 Attenuates Neuronal Pyroptosis after Subarachnoid Hemorrhage in Rats via Regulating the CXCR4/NLRP1 Pathway

Activation of RARα Receptor Attenuates Neuroinflammation After SAH via Promoting M1-to-M2 Phenotypic Polarization of Microglia and Regulating Mafb/Msr1/PI3K-Akt/NF-κB Pathway

Neutrophils and Neutrophil Extracellular Traps Cause Vascular Occlusion and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage in Mice

P2X7 Receptor Suppression Preserves Blood-Brain Barrier through Inhibiting RhoA Activation after Experimental Intracerebral Hemorrhage in Rats

Role of SCH79797 in maintaining vascular integrity in rat model of subarachnoid hemorrhage

Enhancing Th17 cells drainage through meningeal lymphatic vessels alleviate neuroinflammation after subarachnoid hemorrhage

Recombinant soluble form of receptor for advanced glycation end products ameliorates microcirculation impairment and neuroinflammation after subarachnoid hemorrhage

Abstract WMP112: Neutrophil Extracellular Traps Occlude the Cerebrovasculature Causing Delayed Cerebral Ischemia After Subarachnoid Hemorrhage in Mice

Clinical Potential of Immunotherapies in Subarachnoid Hemorrhage Treatment: Mechanistic Dissection of Innate and Adaptive Immune Responses.

VE-cadherin Role of SCH 79797 in Maintaining Vascular Integrity in Rat Model of Subarachnoid Hemorrhage

Targeting CCL20 inhibits subarachnoid hemorrhage-related neuroinflammation in mice